Education and Training
Neuroendocrine Mapping of the Cerebral Cortex
This study is investigating brain regions that share functional connectivity with the hypothalamus and the stimulation of those regions using repetitive transcranial magnetic stimulation (rTMS) to activate the hypothalamus indirectly. The goal of this study is to determine the effectiveness of rTMS in influencing the hypothalamus to better understand the mechanisms between it and the neuroendocrine processes it controls.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- device: Repetitive Transcranial Magnetic Stimulation
Eligibility
Inclusion Criteria:
- Age: 21-55
- Gender: Females and Males
- Weight: Less than 280 pounds
- Mobile
- Normal vision with corrective lenses if necessary
- Fluent in English (written and spoken)
Exclusion Criteria:
- History of epilepsy/seizures (including history of withdrawal/provoked seizures)
- Metal implant in brains (e.g. deep stimulation), cardiac pacemaker, or cochlear
implants
- Shrapnel or any ferromagnetic item in the head
- Showing symptoms of withdrawal from alcohol or benzodiazepines
- Current severe insomnia (must sleep a minimum of 4 hours the night before stimulation)
- Migraine or significant headaches
- Shoulder or neck stiffness
- Over 280 pounds
- In-dwelling ferrous metals
- Left handed
- Abnormal hearing
- Abnormal vision that cannot be corrected with lenses
- Claustrophobia
- Illicit drug use
- Psychotropic medication use
- Marijuana and/or nicotine use
- Psychiatric or neurological conditions
- Endocrine conditions
- History of head trauma with loss of consciousness
Ages Eligible for Study
21 Years - 55 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Keith Sudheimer, Ph.D.
(650) 701-3674
Not Recruiting